Radioembolization gains continuous traction as a primarily palliative radiation treatment for
hepatic tumours. A form of nuclear medicine therapy, Yttrium-90 containing microspheres …

Transarterial radioembolization (TARE) with Yttrium-90 (90 Y) microspheres is a liver-
directed therapy for primary and metastatic disease. This manuscript provides a review of …

Transarterial radioembolization (TARE) is a locoregional radiopharmaceutical therapy
based on the delivery of radioactive 90Y microspheres to liver tumors. The importance of …

Purpose Respiratory motion may impose significant inaccuracies on emission activity
estimation in quantitative SPECT. This effect may be a major issue in dosimetry as used in …

Purpose To perform precision dosimetry in yttrium-90 radioembolization through CT imaging
of radiopaque microspheres in a rabbit liver model and to compare extracted dose metrics to …

Purpose To quantify the relationship of the tumor-to-normal ratio (TNR) attained from the
technetium-99m macroaggregated albumin (MAA) and posttreatment yttrium-90 …

Objective. To evaluate the pre-treatment and post-treatment imaging-based dosimetry of
patients treated with 90Y-microspheres, including accurate estimations of dose to tumor …

Purpose To determine the relationship of tumoral and nontumoral radiation dose to
response and toxicity after transarterial radioembolization (TARE) of breast cancer liver …

Selective internal radiation therapy (SIRT) is a treatment which delivers radioactive
therapeutic microspheres via the hepatic artery to destroy tumorigenic tissue of the liver …

Purpose Prior to 90 Y selective internal radiation therapy (SIRT) treatment, 99m Tc-MAA
scintigraphy imaging is used in the estimation of the lung shunt fraction (LSF). Planar …